Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons · 2026
Patient reported outcomes following surgical reconstruction of acquired Charcot foot deformity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cho Elizabeth, Hodkiewicz Victoria, Huang Nicole W, Feffer Marina, Hamid Kamran S, Schiff Adam P, Pinzur Michael S
Аннотация
BACKGROUND: Charcot foot reconstruction can improve quality of life, however, patient-reported outcomes remain underreported.
METHODS: This was a retrospective study of patients with diabetes-associated Charcot foot arthropathy who underwent reconstruction between 2022 and 2023. Patient reported outcome measures (PROMs) collected were Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference, Physical Function, Global Health, and the Foot and Ankle Disability Index. Patients who completed surveys at all timepoints (preoperatively and 6- and 12-months postoperatively) were included. Generalized estimating equations estimated mean changes in PROM scores; multivariable models assessed the impact of clinical variables.
RESULTS: Twenty-seven patients met inclusion criteria with median age of 59 years and median body mass index (BMI) of 36. Patients demonstrated a significant decrease in Pain Interference at 6 months, but this improvement was not sustained at 12 months. No significant differences were observed in other PROMs.
CONCLUSION: Charcot reconstruction results in meaningful early improvements in patient-reported pain and functional outcomes, however, the durability of these benefits appears limited.
LEVEL OF EVIDENCE: IV, retrospective cohort study.
METHODS: This was a retrospective study of patients with diabetes-associated Charcot foot arthropathy who underwent reconstruction between 2022 and 2023. Patient reported outcome measures (PROMs) collected were Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference, Physical Function, Global Health, and the Foot and Ankle Disability Index. Patients who completed surveys at all timepoints (preoperatively and 6- and 12-months postoperatively) were included. Generalized estimating equations estimated mean changes in PROM scores; multivariable models assessed the impact of clinical variables.
RESULTS: Twenty-seven patients met inclusion criteria with median age of 59 years and median body mass index (BMI) of 36. Patients demonstrated a significant decrease in Pain Interference at 6 months, but this improvement was not sustained at 12 months. No significant differences were observed in other PROMs.
CONCLUSION: Charcot reconstruction results in meaningful early improvements in patient-reported pain and functional outcomes, however, the durability of these benefits appears limited.
LEVEL OF EVIDENCE: IV, retrospective cohort study.